177 related articles for article (PubMed ID: 7700453)
1. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease.
Simpkins JW; Singh M; Bishop J
Neurobiol Aging; 1994; 15 Suppl 2():S195-7. PubMed ID: 7700453
[No Abstract] [Full Text] [Related]
2. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects.
Henderson VW; Paganini-Hill A; Emanuel CK; Dunn ME; Buckwalter JG
Arch Neurol; 1994 Sep; 51(9):896-900. PubMed ID: 8080389
[TBL] [Abstract][Full Text] [Related]
3. The pharmacological management of cognitive dysfunction in Alzheimer's disease.
Vandewoude MF
Acta Clin Belg; 1999 Oct; 54(5):306-11. PubMed ID: 10555391
[No Abstract] [Full Text] [Related]
4. Estrogen replacement therapy, Alzheimer's disease, and mild cognitive impairment.
Mulnard RA; Corrada MM; Kawas CH
Curr Neurol Neurosci Rep; 2004 Sep; 4(5):368-73. PubMed ID: 15324602
[TBL] [Abstract][Full Text] [Related]
5. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
[TBL] [Abstract][Full Text] [Related]
6. Estrogen replacement therapy: effects on the cognitive functioning and clinical course of women with Alzheimer's disease.
Levine AJ; Battista M
Arch Clin Neuropsychol; 2004 Sep; 19(6):769-78. PubMed ID: 15288330
[TBL] [Abstract][Full Text] [Related]
7. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
Strnad J; Bahro M
Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
[No Abstract] [Full Text] [Related]
8. Psychopharmacology and Alzheimer's disease.
Serby M
J Adv Med Surg Nurs; 1989 Mar; 1(2):32-9. PubMed ID: 2664071
[No Abstract] [Full Text] [Related]
9. Surgical menopause and cognitive decline.
Pines A
Climacteric; 2014 Oct; 17(5):580-2. PubMed ID: 24502814
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Hormone Replacement Therapy on Cognitive Function in Female Patients With Alzheimer's Disease: A Meta-Analysis.
Zhou C; Wu Q; Wang Z; Wang Q; Liang Y; Liu S
Am J Alzheimers Dis Other Demen; 2020; 35():1533317520938585. PubMed ID: 32677442
[TBL] [Abstract][Full Text] [Related]
11. Estrogen replacement therapy for cognitive benefits: viable treatment or forgettable "senior moment"?
Marks SJ; Batra RR; Frishman WH
Heart Dis; 2002; 4(1):26-32. PubMed ID: 11975829
[TBL] [Abstract][Full Text] [Related]
12. Mood, cognition and Alzheimer's disease.
Compton J; van Amelsvoort T; Murphy D
Best Pract Res Clin Obstet Gynaecol; 2002 Jun; 16(3):357-70. PubMed ID: 12099667
[TBL] [Abstract][Full Text] [Related]
13. Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives.
Francis PT; Sims NR; Procter AW; Bowen DM
J Neurochem; 1993 May; 60(5):1589-604. PubMed ID: 8473885
[No Abstract] [Full Text] [Related]
14. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
Peskind ER
J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
[TBL] [Abstract][Full Text] [Related]
15. Treatment trial of oxiracetam in Alzheimer's disease.
Green RC; Goldstein FC; Auchus AP; Presley R; Clark WS; Van Tuyl L; Green J; Hersch SM; Karp HR
Arch Neurol; 1992 Nov; 49(11):1135-6. PubMed ID: 1444879
[TBL] [Abstract][Full Text] [Related]
16. Lipid lowering agents to delay cognitive decline in Alzheimer's disease?
de Leeuw FE
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1611-3. PubMed ID: 16291879
[No Abstract] [Full Text] [Related]
17. Effects of antihypertensive therapy on cognitive decline in Alzheimer's disease.
Duron E; Rigaud AS; Dubail D; Mehrabian S; Latour F; Seux ML; Hanon O
Am J Hypertens; 2009 Sep; 22(9):1020-4. PubMed ID: 19590498
[TBL] [Abstract][Full Text] [Related]
18. Does rivastigmine improve cognitive functions or disability in patients with Alzheimer's disease?
Cantisani TA; Celani MG; Righetti E
Neuroepidemiology; 2004; 23(4):209-10. PubMed ID: 15272224
[No Abstract] [Full Text] [Related]
19. Future therapeutic developments of estrogen use.
Fillit H
J Clin Pharmacol; 1995 Sep; 35(9S):25S-28S. PubMed ID: 8530715
[TBL] [Abstract][Full Text] [Related]
20. Ondansetron in the treatment of cognitive decline in Alzheimer dementia.
Dysken M; Kuskowski M; Love S;
Am J Geriatr Psychiatry; 2002; 10(2):212-5. PubMed ID: 11925283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
